OpenAI is actively investigating an unexpected surge in latency and errors affecting both ChatGPT users and developers using ...

An increasing number of individuals are resorting to cannabis as a quick solution for improved sleep… but is it genuinely safe over an extended period? Massive tornado tears through Nebraska town ...

Call it the battle of the cookie empires. The News Leader wanted to test Crumbl Cookies against Insomnia Cookies. While not located in Staunton or Augusta County, both franchises have locations in ...

New data show that 1 in 8 Americans are using sleep aids such as magnesium, melatonin or CBD. By Amanda Schupak One in eight American adults is regularly taking some kind of sleep aid, like a ...

Data API Builder helps developers expose database objects through REST and GraphQL without building extensive custom data access code. Steve Jones' Visual Studio Live! San Diego 2026 session will show ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2011, I was six months pregnant with my youngest son, chasing an ...

A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...

Getting a good night’s sleep is something that I’ve struggled with my entire life, and so if there's anything I can do to help me when I wake up in the middle of the night, I’m willing to try it. I ...

Sleep scores may be one of the most-checked metrics in wearable health tracking, but the companies behind them haven't agreed on a shared language. A Garmin wearer with a 75 is in "Fair" territory. An ...

Are you a subscriber to Anthropic's Claude Pro ($20 monthly) or Max ($100-$200 monthly) plans and use its Claude AI models and products to power third-party AI agents like OpenClaw? If so, you're in ...

After notching a phase 2 trial win, Idorsia’s insomnia med Quviviq (daridorexant) is one step closer to potentially becoming a first-in-class treatment for children. The drug, a dual orexin receptor ...